FDA’s Shuren: No retaliation against companies who criticize FDA
There will be no retaliation against companies who tell the U.S. Food and Drug Administration that its processes are too burdensome and unpredictable. Those are the words of Jeffrey Shuren, director of the Center for Devices and Radiological Health at the FDA, according to a report by FDA News’ Device and Diagnostics Letter. Last week, Shuren […]